Our Mission
Fearlessly pioneering novel therapies to make meaningful impact and provide hope for patients with fibrotic diseases.
Jonathan Barratt, MD, PhD, FRCP 
The Mayer Professor of Renal Medicine, University of Leicester
Joseph Bonventre, MD, PhD
Chief Emeritus, Division of Renal Medicine, Brigham and Women’s Hospital, Samuel A. Levine Distinguished Professor, Harvard Medical School
Flavia Castelino, M.D.
Associate Professor of Medicine, Harvard Medical School, Division of Rheumatology, Massachusetts General Hospital
David Cherney, MD, PhD, FRCP
Professor of Medicine and Gabor Zellerman Chair of Nephrology Research, University of Toronto
Lara Dimick-Santos, M.D.
Consultant, former FDA medical reviewer
Scott Friedman, M.D.
Dean for Therapeutic Discovery, Fishberg Professor of Medicine, Director, Institute for Liver Research, Icahn School of Medicine at Mount Sinai
Matthias Kretzler, MD, PhD
Warner-Lambert/Parke-Davis Professor of Internal Medicine/Nephrology, Research Professor, Computational Medicine and Bioinformatics, University of Michigan
Robert Lafyatis, M.D.
Professor of Medicine, Division of Rheumatology & Clinical Immunology, University of Pittsburgh Medical Center
Rohit Loomba, M.D., MHSc
Professor of Medicine, Chief of the Division of Gastroenterology and Hepatology, University of California San Diego
Toby Maher, M.D., Ph.D.
Professor of Medicine, Director of Interstitial Lung Diseases, University of Southern California
Sydney Montesi, M.D.
Assistant Professor of Medicine, Harvard Medical School, Pulmonary and Critical Care Medicine, Massachusetts General Hospital
John Varga, M.D.
Professor of Medicine, Chief of the Division of Rheumatology, University of Michigan